USANA Health Sciences, Inc. (NYSE:USNA) Q1 2021 Earnings Conference Call April 28, 2021 11:00 AM ET Corporate Participants Patrique Richards - Executive Director of Investor Relations & Business Development Kevin Guest - Chairman & Chief Executive Officer Jim Brown - President Doug Hekking - Chief Financial Officer Brent Neidig - Chief Officer and Managing Director of China Conference Call Participants Doug Lane - Lane Research Sebastian Barbero - Jefferies Operator Good day, and welcome to the USANA Health ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 2, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ____________ Commission file number: 001-35024 _______________________________ USANA HEALTH SCIENCES, INC. (Exact name of registrant as specif ...

USANA Health Sciences, Inc. (NYSE:USNA) Q4 2020 Earnings Conference Call February 10, 2021 11:00 AM ET Company Participants Patrique Richards - Executive Director of Investor Relations & Business Development Kevin Guest - Chairman & Chief Executive Officer Jim Brown - President Doug Hekking - Chief Financial Officer Conference Call Participants David Bain - ROTH Capital Sebastian Barbero - Jefferies Doug Lane - Lane Research Ivan Feinseth - Tigress Financial Partners Operator Good day, and welcome to the US ...

® THE CELLULAR NUTRITION COMPANY Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking statements, which involve a number of risks and uncertainties and should be considered in conjunction with the cautionary statements contained in our most recent filings with the SEC. Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking s ...

Financial Data and Key Metrics Changes - The company reported record earnings per share and sales approaching $300 million for Q3 2020, driven by strong demand for nutritional products and successful incentive programs [7][9]. - The full-year guidance was raised to reflect the strong Q3 results and expectations for Q4 [9]. Business Line Data and Key Metrics Changes - A record number of active customers was achieved during the quarter, indicating strong engagement and demand for the company's products [7]. - The company successfully executed virtual conventions, which allowed for a larger audience reach compared to in-person events [8]. Market Data and Key Metrics Changes - The company noted that while China is recovering from the impacts of COVID-19, the growth has not yet reached the levels seen in 2017 and 2018, but the outlook remains positive [13][16]. - Approximately 5% of sales in the Greater China region come from Hong Kong [26]. Company Strategy and Development Direction - The company is focusing on organic growth and exploring deal flow opportunities to accelerate growth in new geographic regions and product lines [31]. - The company plans to continue leveraging virtual platforms for events, which have proven effective in reaching a broader audience [46][48]. Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying business strength despite the challenges posed by the COVID-19 pandemic [9]. - There is optimism about future growth, particularly in the context of product rollouts and market recovery [40][49]. Other Important Information - The company is seeing a lift in demand for products designed to support immune function, which has been a trend throughout the year [38]. - The company is considering investing in a platform for virtual meetings but is currently utilizing existing platforms like Zoom and Webex [44][48]. Q&A Session Summary Question: Insights on China and Sales Recovery - Management acknowledged the slower recovery in China but remains confident in the market's potential and is actively engaging in promotions to revitalize sales [12][18]. Question: Impact of COVID-19 on Margins - Management noted that while there were higher incentives and costs, lower SG&A expenses due to the absence of global conventions helped maintain margins [20][22]. Question: Capital Allocation and Share Buybacks - The company prioritizes organic growth and is looking for the right opportunities for share repurchase, with a focus on maintaining flexibility [31][32]. Question: Product Trends and Distributor Feedback - There is a continued interest in immune-supporting products, and distributors are eager to return to in-person meetings [38][41]. Question: Virtual Meeting Platforms - The company is currently using popular platforms like Zoom and Webex for virtual meetings, which have been effective in reaching a wider audience [44][48]. Question: Active Nutrition Line Rollout - The rollout of the Active Nutrition line is planned for early next year, with a focus on regulatory compliance and market-specific launches [49].

® THE CELLULAR NUTRITION COMPANY and and and a state 177 al i 20 t 7 4,28 23 Key | --- | --- | --- | |-------------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Management will make forward-looking statements | | | | during this presentation. Actual results could differ | | | | from those projected in such forward-looking | | | | --- | --- | --- | |----------------------------------------------------------------------------------------- ...

Financial Data and Key Metrics Changes - The company raised its full-year guidance to reflect a solid second quarter and current business momentum [11] - Promotions introduced in Q2 contributed approximately $9 million to $10 million in revenue for the quarter [15][18] Business Line Data and Key Metrics Changes - The company successfully hosted its first all-virtual Asia-Pacific Convention, which received positive feedback and high attendance [8][9] - The promotions and incentives strategy is expected to continue driving customer growth in the second half of the year [11] Market Data and Key Metrics Changes - In Greater China, sales grew just under 2% in constant currency, with Hong Kong's challenging environment negatively impacting overall performance [22] - China experienced a sequential decline of about 4% in sales compared to Q1, attributed to the success of promotions in the first quarter [35][36] Company Strategy and Development Direction - The company remains committed to long-term growth initiatives and adapting to the evolving operating environment due to COVID-19 [11] - A hybrid approach for future conventions is anticipated, combining in-person and virtual elements to leverage technology [32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strength of the underlying business and growth strategies for the remainder of 2020 and beyond [11] - The health and safety of employees and customers remain top priorities, influencing operational plans [10] Other Important Information - The company has not faced significant supply chain issues during the quarter, managing to control stock levels effectively [44] - The Active Nutrition product line is set for a rollout in early 2021, with a focus on community support and enhanced marketing strategies [49][50] Q&A Session Summary Question: Impact of promotions on Q2 results - Promotions in Q2 added approximately $9 million to $10 million in revenue, with expectations for continued momentum in Q3 [15][18] Question: Performance in China - China saw a sequential decline of about 4% in sales, primarily due to the success of promotions in Q1 [35][36] Question: Competitive environment and pricing strategy - The company has not seen significant competitive pressure but remains focused on maintaining a strong value proposition [24] Question: Virtual convention plans - The upcoming convention will be virtual, featuring product launches and entertainment, with expectations for higher attendance than in-person events [30][31] Question: Active Nutrition product line strategy - The Active Nutrition line will roll out in early 2021, focusing on community support and leveraging athlete endorsements for marketing [49][50]

® THE CELLULAR NUTRITION COMPANY and and and a state 177 al i 20 t 7 4,28 23 Key | --- | --- | --- | |-------------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Management will make forward-looking statements | | | | during this presentation. Actual results could differ | | | | from those projected in such forward-looking | | | | --- | --- | --- | |----------------------------------------------------------------------------------------- ...

USANA Health Sciences Inc. (NYSE:USNA) Q1 2020 Earnings Conference Call April 22, 2020 11:00 AM ET Company Participants Patrique Richards - Investor Relations Jim Brown - President Doug Hekking - Chief Financial Officer Conference Call Participants Steph Wissink - Jefferies Doug Lane - Lane Research Ivan Feinseth - Tigress Financial Partners Operator Good day and welcome to the USANA Health SciencesÂ' First Quarter Conference Call. TodayÂ's conference is being recorded. And at this time, I would like to tur ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________ FORM 10-K (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Utah 87-0500306 3838 West Parkway Blvd., Salt Lake City, Utah 84120 (Address of principal executive offices, Zip Code) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscalyear ended December 28, 2019 or ¨ TRANSITION REPO ...